Last verified 2026-08-16
Home sleep test vs in-lab study: what each one measures
A home sleep apnea test and an in-lab sleep study can both evaluate sleep apnea, but they do not measure the same things. The biggest difference is that a full in-lab study can tell when sleep actually begins and ends. A typical home test cannot.
That difference affects the number you get at the end of the study. It also affects what the test can miss and, in some cases, whether your insurer will accept the result when you later ask it to pay for treatment.
Which test is right for you is a clinical decision. What you can know before the test is what each one records and what paperwork you may need afterward.
What an in-lab study records
A full polysomnogram is done overnight in a sleep facility with a technician present. It records brain activity, eye movement, muscle activity, heart rhythm, airflow, breathing effort, and blood oxygen at the same time.
The brain-wave recording is what lets the study separate time asleep from time awake. If you lie in bed awake for 2 hours, those 2 hours are not counted as sleep when the breathing-event rate is calculated.
What a home test records
A home sleep apnea test usually records airflow, breathing effort, blood oxygen, and sometimes heart rate. Simpler devices collect less.
Most home tests do not record brain activity. The device knows how long it was recording, but it does not know exactly how much of that time was sleep.
Your report may use any of three terms, and they are not interchangeable. The apnea-hypopnea index, or AHI, divides apneas and hypopneas by hours of actual sleep. A full sleep study can measure that sleep time with brain-wave recording. The respiratory event index, or REI, is the term the American Academy of Sleep Medicine recommends for home testing when sleep is not directly measured. REI divides respiratory events by monitoring time, which is derived from the recording rather than EEG-confirmed sleep. In many clinical contexts, respiratory disturbance index, or RDI, can also include respiratory effort-related arousals. Medicare uses RDI differently in its PAP coverage policy: for Type III, Type IV, and other home studies, CMS defines RDI as apneas plus hypopneas per hour of recording and excludes respiratory effort-related arousals.
The arithmetic shows why the distinction matters. If a home device counts eight hours of monitoring time and you were actually asleep for six, twenty events read as 2.5 an hour. The same twenty events divided by six hours of measured sleep read as 3.3 an hour. When monitoring or recording time is longer than true sleep time, the event rate is lower.
So a home result understates severity whenever you spend a meaningful part of the recording awake. It is not an error in the test. It is what the test is able to measure. If your home test comes back borderline or normal but your symptoms and clinical risk still point strongly toward sleep apnea, the result deserves another look rather than being treated as the final word.
Medicare’s criteria account for this difference. Sleep time can only be measured in a facility-based or full inpatient study, and shorter recordings have minimum event-count requirements intended to keep a short or fragmented recording from producing a misleading index.
What a home test can miss
A home test does not provide sleep-stage information. Some breathing abnormalities cluster in particular stages of sleep, and a typical home device cannot show that pattern.
It also generally does not detect limb movements or many other sleep disorders that can repeatedly disturb sleep. Arousals that show up on brain-wave monitoring but are not accompanied by an oxygen drop can be missed as well.
Some home devices also detect complex or central breathing patterns poorly.
None of that makes home testing useless. It makes it a narrower test. The ordering clinician decides whether that narrower measurement is enough for the clinical question being asked.
What insurers require
Treatment coverage usually depends on the diagnosis coming from a test your payer recognizes.
For Medicare, the sleep test must be FDA-approved as a diagnostic device, ordered by your treating practitioner, and performed by an entity that qualifies as a Medicare provider of sleep tests. Medicare also requires an in-person clinical evaluation before the sleep test.
The order of those steps matters. If you buy a direct-to-consumer test first and only afterward see a clinician for treatment, an otherwise accurate result may still fail to support a covered treatment claim if your plan required evaluation first, testing second, and the treatment order afterward.
If insurance coverage matters to you, confirm the testing sequence before you pay for a test on your own.
Direct-to-consumer tests
A direct-to-consumer home test can shorten the wait for an initial answer. Some services include a telehealth consultation and clinician review. Others are closer to a testing service that sends you a report.
Before you order one, find out four things:
- whether your insurer recognizes that specific test;
- whether a physician reviews the result and issues an order;
- what happens after a positive result, including whether treatment can be prescribed through the same service; and
- whether the sequence meets your plan’s requirement for evaluation before testing.
You can end up with a perfectly real test result and still have to repeat part of the process if the documentation chain does not meet your payer’s rules.
After the result
Either test produces an event index and a severity classification. A clinician reviews the result and, when treatment is indicated, writes the treatment order.
That order connects the sleep study to what comes next, including a PAP machine, an oral appliance, and many prior-authorization requests.
Keep a copy of your full sleep study report. You will be asked for it again. The index, the event count, and the report itself are repeatedly used to establish coverage later.
→ Find a sleep physician or lab near you → Prior authorisation, by treatment and payer
This page describes what each test measures and what payers require. It does not determine which test is appropriate for a particular person. That depends on symptoms, risk factors, medical history, and the clinician performing the evaluation.